Cosentyx® Letter for the consulting physician in case of treatment switch (French)
Download French document
To receive by post, click on the "Add to card" button below
Cosentyx® Letter for the General Practitioner (French)
Download French document To receive by post, click on the "Add to card" button belowCosentyx® Letter for the consulting physician in case of treatment switch (Dutch)
Download Dutch document To receive by post, click on the "Add to card" button belowCosentyx® Letter for the General Practitioner (Dutch)
Download Dutch document To receive by post, click on the "Add to card" button belowCosentyx® - PSA
Efficacy - Cosentyx PsA
Reimbursement - Cosentyx PsA
Mechanism of action - Cosentyx PsA
Cosentyx (secukinumab) is a fully human IgG1/κ monoclonal antibody that selectively binds to and neutralizes the proinflammatory cytokine interleukin-17A (IL-17A). 1 Cosentyx works by targeting IL-17A and inhibiting its interaction with...
Twitter Linkedin Facebook Pinterest Google plusPatient Resources - Cosentyx PsA
Dosing - Consentyx PsA